Skip to main content
Clinical Trials/ITMCTR2000002923
ITMCTR2000002923RecruitingPhase 1

Effect of Fu's subcutaneous needling therapy on abnormal uterine bleeding

Beijing Shijitan Hospital, CM0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
20 to 55 (—)
Sex
Female

Inclusion Criteria

  • 1. Aged 20-45 years old;
  • 2. Preoperative diagnosis of benign gynecological disease;
  • 3. Laparoscopic or uterine laparoscopic surgery was planned, and there was no vaginal bleeding before the operation

Exclusion Criteria

  • 1. Patients without postoperative vaginal bleeding were excluded;
  • 2. Postoperative pathological diagnosis of malignant tumors, such as cervical cancer, ovarian cancer and endometrial cancer, was excluded
  • 3. Exclude pregnancy-related diseases such as ectopic pregnancy;
  • 4. Excluded patients after total hysterectomy;
  • 5. Exclude patients with cervical lesions;
  • 6. Exclude patients with vaginal bleeding caused by blood diseases and immune diseases.

Investigators

Sponsor
Beijing Shijitan Hospital, CM

Similar Trials

Effect of Fu's subcutaneous needling... | Clinical Trial